CSIMarket


Usana Health Sciences Inc   (USNA)
Other Ticker:  
 


 

Usana Health Sciences Inc

USNA's Financial Statements and Analysis



Usana Health Sciences Inc reported in the forth quarter of 2023 net earnings per share of $0.87 an increase by 30.06 % year on year from $0.67 and an improvement of 46.68 % from $0.59 realized in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 0.87 $  222 Mill
$+0.20     +30.06 % $-6M     -2.72 %



Usana Health Sciences Inc 's Revenue fell by -2.72 % in forth quarter of 2023 (Dec 30 2023) year on year, to $222 million and advanced by 4.19 % sequentially.


Usana Health Sciences Inc is

More on USNA's Income Statement



Usana Health Sciences Inc 's net income of $16.766 million in the forth quarter of 2023 increased by 31.04 % from net earnings of $12.795 million achieved in IV. Quarter a year ago.

Sequentially net earnings grew by 47.76 % from net income of $11.347 million realized in previous quarter.

More on USNA's Growth

Usana Health Sciences Inc Inventories
Inventories declined by -8.4 % to $61.45 million from IV. Quarter a year ago, sequentially inventories rose by 2.29 %. USNA's Cash flow In the forth quarter of 2023 company's net cash flow was $23 million, capital expenditures fell by -3.285122.95%, to $-7 millions compare to same quarter a year ago

More on USNA's Cash flow Statement


Usana Health Sciences Inc does not pay out common stock dividend.

In trailing twelve-month period Usana Health Sciences Inc earned $ 3.65 cash per share, on a free-cash flow basis 110.74 % of net earning per share.

Book value grew by 5.93 % sequentially to $25.72 per share, 98.05% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 23.29 per share from $ 21.89.

Company repurchased 0.04 million shares or 0.22 % in Dec 30 2023.
Interest Coverage Ratio was 392.04. Debt Coverage Ratio was 522.72.

More on USNA's Dividends

 Market Capitalization (Millions) 969
 Shares Outstanding (Millions) 19
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 920
 Net Income (TTM) (Millions $) 64
 Cash Flow (TTM) (Millions $) 42
 Capital Exp. (TTM) (Millions $) -14
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,788




Usana Health Sciences Inc does not pay out common stock dividend.

In trailing twelve-month period Usana Health Sciences Inc had $ 3.65 cash flow per share, on a free-cash flow basis 110.74 % of net earning per share.

Book value grew by 5.93 % sequentially to $25.72 per share, 98.05% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 23.29 per share from $ 21.89.

Company repurchased 0.04 million shares or 0.22 % in Dec 30 2023.
Interest Coverage Ratio was 392.04. Debt Coverage Ratio was 522.72.

More on USNA's Balance Sheets

 Market Capitalization (Millions) 969
 Shares Outstanding (Millions) 19
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 920
 Net Income (TTM) (Millions $) 64
 Cash Flow (TTM) (Millions $) 42
 Capital Exp. (TTM) (Millions $) -14
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1,788
   


  News about Usana Health Sciences Inc Earnings

Usana Health Sciences Inc Sees Profits Surge Despite Revenue Dip

Despite a slight decrease in revenue during the October to December 2023 period, Usana Health Sciences Inc (USNA) managed to raise its earnings per share (EPS), showing significant growth in profit. The company reported a surge of 30.06% in profit per share to $0.87, while revenue fell by -2.722% to $221.76 million year on year.
Comparing these results with the prior financial reporting period, Usana Health Sciences Inc demonstrated impressive growth. EPS soared from $0.59 per share, and revenue advanced by 4.195% from $212.84 million. This shows that the company is continuing to increase its profitability, even in the face of slightly lower revenue.
Furthermore, Usana Health Sciences Inc highlighte...

Usana Health Sciences Inc Struggles as Revenue Regresses in Third Quarter of 2023 Earnings Season

My Experience and Analysis of Usana Health Sciences Inc's Financial Results
As a financial analyst and avid follower of the stock market, I have closely examined the latest financial results of Usana Health Sciences Inc and I am here to provide some insight into what these numbers could mean for the company and its shareholders.
In the fiscal third quarter of 2023, Usana Health Sciences Inc experienced a significant decline in income. The company's income fell by -24.36% to $0.59 per share compared to $0.78 per share a year ago. This is certainly a cause for concern, as investors always hope to see consistent growth in a company's income. Additionally, the income also faded by -33.71% from $0.89 per ...

Usana Health Sciences Inc Faces Bleak Future as Revenue Plummets in Q2 2023



The latest financial report from Usana Health Sciences Inc paints a concerning picture for the company's performance. Both revenue and net income have witnessed a significant decline, causing investors to raise concerns about the stock's future prospects. In this article, we analyze the key figures from the company's recent fiscal period and shed light on the challenges faced by Usana Health Sciences Inc.
Revenue Plummets:
During the most recent fiscal period, Usana Health Sciences Inc's revenue suffered a substantial decline of 12.823% year on year. Comparing the figures from the same three months a year earlier, revenue decreased from $272.87 million to $237.88 million. This downward tren...

USANA Health Sciences Boosts Revenues by 6.455%, Showcasing Stellar Performance in Q1 2023

USANA Health Sciences Inc, a global nutritional company headquartered in Utah, reported impressive financial results for the first quarter of 2023. The company saw a revenue increase of 6.455% to $248.36 million, compared to $233.30 million during the same time period in the previous year.
Earnings per share (EPS) also showed a significant increase, jumping by 21.79% to $0.95, compared to $0.78 in the prior year reporting period. Revenue advanced by 8.949% from the previous period, while EPS soared by 42.77% from $0.67 per share.
The company's net earnings also showed year-on-year growth, increasing by 23.14% from $14.929 million in the first quarter of 2022 to $18.383 million in the first quarter o...


Date modified: 2024-02-28T16:57:59+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com